Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **transient receptor potential vanilloid 1 receptor** (**TRPV1**) is a non-selective cation channel belonging to the transient receptor potential (TRP) family, specifically the vanilloid subfamily. It is best known as the molecular target for capsaicin—the active component in chili peppers—and is also referred to as the "capsaicin receptor" or "vanilloid receptor 1." Structurally, TRPV1 forms a tetrameric complex with each subunit containing six transmembrane domains; it shares architectural similarities with voltage-gated potassium channels. The primary biological functions of TRPV1 include detection of noxious heat (>43°C), mediation of inflammatory thermal hyperalgesia, regulation of body temperature, and transmission of painful stimuli from peripheral sensory neurons. It plays a significant role in various pathological conditions involving chronic pain and inflammation. Pharmacologically important ligands include agonists such as capsaicin and resiniferatoxin—which activate the channel—and antagonists like capsazepine that inhibit its function. Due to its central role in nociception and inflammation pathways, TRPV1 is considered an important therapeutic target for novel analgesics but presents safety challenges related primarily to thermoregulation.
Agonists activate the ion channel to allow influx of cations such as Ca²⁺ and Na⁺, leading to depolarization and neuronal activation. Antagonists block the ion conduction pore or allosteric sites to inhibit activation by endogenous or exogenous ligands.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential vanilloid 1 receptor (TRPV1).